-

Cell & Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Stages of Development, with No Marketed CGTs to Date. - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cell & Gene Therapies in Respiratory Disorders: Therapeutic Analysis" report has been added to ResearchAndMarkets.com's offering.

The cell and gene therapies (CGTs) landscape for respiratory diseases is currently in the early stages of development, with no marketed CGTs to date.

Reasons to Buy

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the CGT in Respiratory market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact Respiratory disease targeting CGT therapeutics market in the future.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Key Topics Covered:

1. Preface
1.1. Contents
1.2. Abbreviations
1.3. Related Reports

2. Executive Summary

3. Introduction and Scope

4. Current Treatment Options
4.1. What is Cell & Gene Therapy?
4.2. History of the Development of CGT in Respiratory Disorders

5. Unmet Needs
5.1. Challenges and Opportunities in CGT in Respiratory Disorders

6. Regulations
6.1. Regulation of CGTs in the 8MM

7. Future Market Assessment
7.1. Top 20 Respiratory Disorders with CGT Development
7.2. Top Five Respiratory Disorders with the Most CGT Pipeline Assets
7.3. Top Five Respiratory Disorders Stratified by Molecule Type
7.4. CGT in Respiratory Disorders -Phase II/III
7.5. Industry Trends in the Application of CGTs in Respiratory Disorders
7.6. CGT Market Catalyst are limited to a single company in the next 5 years

8. Likelihood of Approval and Phase - Transition Success Rate Analysis
8.1. CGT Candidates Have Lower PTSR vs. Indication Benchmarks

9. Sales Forecast
9.1. Sales are forecast to reach $62 million by 2030

10. Appendix

Companies Featured

  • Vertex Pharmaceuticals Inc
  • MediPost Co Ltd
  • KYORIN Pharmaceuticals Co Ltd
  • Bonus BioGroup Ltd
  • Armata Pharmaceuticals Ltd
  • Translate Bio Inc
  • 4D Molecular Therapeutics Inc
  • Suzhou Regend Therapeutics Co Ltd
  • MiNK Therapeutics Inc
  • Human Life CORD Japan Inc
  • Nuwacell Biotechnology Co Ltd
  • Taskin Bioregeneration Co

For more information about this report visit https://www.researchandmarkets.com/r/f94g3w

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Poland Investment Funds and Asset Management Market Report 2026, Profiles of TFI, Pekao, Santander, PKO, Allianz, Goldman Sachs - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Investment Funds and Asset Management Market in Poland, 2024-2026" report has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive overview of the investment funds and asset management sector in Poland. Analysis covers the main pillars of the market, including: mutual funds, insurance, and pension assets. The report also mid-term forecast of key volumes for the period 2025-2027. The data has been presented in a form of horizontal pr...

Europe Data Center Colocation Market Outlook & Forecast Report 2025-2030 Featuring Major Players - Digital Realty, Equinix, NTT DATA, Global Switch, CyrusOne, Ark Data Centres - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Europe Data Center Colocation Market - Industry Outlook & Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The Europe Data Center Colocation Market was valued at USD 9.45 Billion in 2024, and is projected to reach USD 35.73 Billion by 2030, rising at a CAGR of 24.82%. The Europe data center colocation market is expected to witness cumulative investments of approximately $144.03 billion, of which, the Western Europe is slated to ac...

GCC Construction Equipment Market Research Report 2025-2030 Featuring Key Vendors - Caterpillar, Komatsu, Volvo, Hitachi, SANY, XCMG, JCB, Liebherr, Kobelco, and Zoomlion - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "GCC Construction Equipment Market Research Report 2025-2030" report has been added to ResearchAndMarkets.com's offering. The GCC Construction Equipment Market was sized at 68,499 Units in 2024, and is projected to reach 94,499 Units by 2030, rising at a CAGR of 5.51%. Governments in the UAE and Saudi Arabia continue to prioritize urban growth and diversification, with Dubai's long-term 2040 Urban Master Plan and the Saudi Vision 2030-linked mega-projects fuelling o...
Back to Newsroom